Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort.
Vanlerberghe J, Dezoteux F, Martin C, Jachiet M, Soria A, Tétart F, Modeste-Duval AB, Bursztejn AC, Misery L, Aubin F, Lasek A, Leleu C, Du-Thanh A, Pasteur J, Pralong P, Nosbaum A, Droitcourt C, Viguier M, Tauber M, Seneschal J, Barbarot S, Staumont-Sallé D. Vanlerberghe J, et al. Among authors: dezoteux f. J Am Acad Dermatol. 2023 Apr;88(4):900-904. doi: 10.1016/j.jaad.2022.10.034. Epub 2022 Oct 21. J Am Acad Dermatol. 2023. PMID: 36280001 Free article. No abstract available.
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.
Guttman-Yassky E, Bahadori L, Brooks L, Clark KL, Grindebacke H, Ho CN, Katial R, Pham TH, Walton C, Datto CJ; HILLIER study group†. Guttman-Yassky E, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1211-e1214. doi: 10.1111/jdv.19195. Epub 2023 Jun 12. J Eur Acad Dermatol Venereol. 2023. PMID: 37178404 Clinical Trial. No abstract available.
Pyoderma gangrenosum developing in a patient treated with dupilumab.
Nasseh J, Abi Rached H, Dumitru I, Staumont-Sallé D, Dezoteux F. Nasseh J, et al. Among authors: dezoteux f. JAAD Case Rep. 2021 Dec 17;20:58-60. doi: 10.1016/j.jdcr.2021.12.009. eCollection 2022 Feb. JAAD Case Rep. 2021. PMID: 35097179 Free PMC article. No abstract available.
Omalizumab in chronic inducible urticaria: A retrospective, real-life study.
Fialek M, Dezoteux F, Le Moing A, Karimova E, Ramdane N, Pape E, Azib-Meftah S, Staumont-Sallé D. Fialek M, et al. Among authors: dezoteux f. Ann Dermatol Venereol. 2021 Dec;148(4):262-265. doi: 10.1016/j.annder.2021.04.010. Epub 2021 Jul 8. Ann Dermatol Venereol. 2021. PMID: 34247853 No abstract available.
Atopic dermatitis in elderly adults.
Dezoteux F, Astrid B, Chuffard M, Drumez E, Azib S, Staumont-Sallé D. Dezoteux F, et al. Eur J Dermatol. 2019 Aug 1;29(4):371-374. doi: 10.1684/ejd.2019.3609. Eur J Dermatol. 2019. PMID: 31486404
48 results